DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
van Schaik IN, Bril V, van Geloven N. , et al; PATH study group.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Neurol 2018;
17 (01) 35-46
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.